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Conclusion: When developing new drugs against Mycobac-
terium tuberculosis, it is important to note that this bacteria has
a solid and chemically resistant cell wall. Therefore, anti-TB agents
are speciﬁc and do not act on other pathogenic bacteria, and vice
versa - the huge variety of available antibiotics does not affect
the mycobacteria. For all tested compounds there is no correla-
tion between their antimycobacterial activity and activity against
other microorganisms. This indicates that the action of all potent
derivatives ((+)-camphor and (-)-fenchones) are speciﬁc to the
Mycobacteriumtuberculosis.All of themare stable, non-toxic against
human cells and show antimycobacterial activity in the nanomolar
range being 60 times more active than ethambutol.These results
can be considered an important starting point for design of new
effective antitubercular drugs.
http://dx.doi.org/10.1016/j.ijid.2016.02.872
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Background: Tuberculosis is an infectious disease causedby the
bacillusMycobacterium tuberculosis. Mycobacteremia is a key event
in the pathogenesis of tuberculosis and development of extra-
pulmonary TB. Genotyping of M. tuberculosis isolates is useful for
surveying the dynamics of TB infection, identifying new outbreaks,
and preventing the disease. We attempted to estimate the preva-
lence of M. tuberculosis bacteremia and its genotypes.
Methods & Materials: Suspected cases of tuberculosis were
screened formycobacteremia by culturing 5ml of peripheral blood
sample in the MB/BacT® culture system (bioMérieux, France).
Flashed positive bottles were screened for M. tuberculosis using in-
house multiplex PCR and further screened for drug susceptibility.
All isolates were subjected to spoligotyping, 24 loci MIRU-VNTR,
TbD1+/1 and RD analysis. Genotyping analysiswas performed using
SIT-VIT web and MIRU-VNTRplus online tools.
Results: Blood culture was performed from 469 patients (306
extrapulmonary, 50 pulmonary and 113 disseminated TB cases).
Seventy seven (16.4%) of these blood cultures were positive by
MB/BacT®. Of the 77 isolates, 36 (11.7%) were patients had extra-
pulmonary TB, 34 (30%) disseminated TB, and 7 (14%) pulmonary
tuberculosis. Among the culture positives 67 (87%) were identiﬁed
as M. tuberculosis and 10 (13%) as mycobacteria other than tuber-
culosis using in-house multiplex PCR. Spoligotyping identiﬁed 65
isolates (97%) belong to 16 previously described Share Types, while
the remaining two isolates had unique/un-identiﬁed Share Types
patterns based upon SIT-VIT web. Among them ST26 (CAS1 DEL)
was more predominant (49.2%) followed by ST25 (CAS1 DEL)
(9.2%), ST1 (Beijing) (9.2%) andST19 (EAI2 MANILLA) (7.6%). Largest
number of clustering of isolateswas detected in Beijing (100%), CAS
(97.4%), and EAI (81.8%) by spoligotyping. TbD1 analysis showed
that majority of the isolates (83.5%) were modern lineages (TbD1¯)
and 11 (16.4%) isolates belong to ancient linage (TbD1+). All the
ancient lineage isolates belong to EAI lineage.
Conclusion: CAS lineage was predominantly found among
mycobacteremiapatients. This pattern is notdifferent fromthepre-
dominance of mycobacterial isolates genotyped from pulmonary
TB cases.
http://dx.doi.org/10.1016/j.ijid.2016.02.873
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Background: The problems with any PCR method using DNA
sequences as targets for ampliﬁcation include false-positive results,
the inability to detect a difference between viable and nonvi-
able organisms and the inability to determine drug susceptibility.
Instead of DNA detecting assays, using RT-qPCR to assess the
expression of the 85B mRNA gene of M. tuberculosis indicates the
presence of a viable organism. In this study, we used the mRNA
coding for 85B antigen complex which is present in all mycobac-
teria. We aimed to assess the diagnostic performance of RT-qPCR
method by comparing with the real-time PCR Cobas TaqMan MTB
kit.
Methods & Materials: A total of 54 cases including 32 (17
males, 15 females) patientswith conﬁrmed tuberculosis and 22 (13
males, 9 females) individualswithout tuberculosiswere includedas
patient and control groups, respectively. Themean ages of 30males
and 24 females were 37,06 ± 8,88 and 36,75 ± 8,96, respectively.
Decontamination with N-acetyl-L-cysteine and sodium hydrox-
ide (NALC–NaOH) at 2% and Mycobacterial Growth Indicator Tube
(MGIT) 960 system was used for the laboratory diagnosis of spu-
tum samples. Decontaminated samples were used for the manual
extraction of M. tuberculosis DNA and 85B mRNA. Extracted DNA
was used for Cobas TaqManMTBDNA qPCR kit (Roche Diagnostics)
in a cobas TaqMan 48 analyzer. For RT-qPCR method, total RNA
was extracted from the sputum specimen using standard TRIzol
protocol (Invitrogen) and 85B mRNA analyses were performed on
LightCycler 480 II system.
Results: A signiﬁcant difference was detected between patients
and control groups by RT-qPCR method (p<0.001) and Cobas Taq-
ManMTBDNA qPCR kit (p=0.0027). Sensitivity, speciﬁcity, positive
and negative predictive values and kappa coefﬁcient were deter-
mined as 97%, 95%, 97%, 95%, 0.89% for RT-qPCR method and 91%,
